![Memorial Sloan Kettering medical oncologist Ezra Rosen](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/201394/3x2/rosen-ezra_200814_09_1200x800.jpg?h=10d202d3)
Ezra Rosen, MD, PhD
Breast Medical Oncologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
About Me
- Assistant Attending Physician
I am a medical oncologist who specializes in breast cancer and early phase clinical trials.
I study the molecular mechanisms that drive a patient’s cancer, with the goal of bringing new treatments with higher efficacy and improved tolerability to the clinic. As a clinical investigator, I believe that clinical trials offer hope to patients through the development of new treatment options. When caring for my patients, I strive to help them better understand their disease which can make people feel informed and empowered. I present often complex treatment options in the clearest possible way to offer the best therapy to each patient based on their needs. Every day I work with an amazing interdisciplinary team of nurses, surgeons, radiation oncologists, pathologists, radiologists, and biologists, all united with the common goal of delivering the best cancer care.
A breast oncologist is a doctor with special training in breast cancer.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Breast Cancer
- Clinical Trials
- Developmental Therapeutics
- Molecular Targeted Therapies
Education
- MD, PhD, University of California, Los Angeles
Residencies
- Internal Medicine - Columbia University Medical Center
Awards and Honors
- Young Investigator Award, American Society of Clinical Oncology (2020)
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Contact and Location
Dr. Rosen sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Rosen
- A Phase 1 Study of CFT1946 in People With Solid Tumors Containing Mutations in BRAF-V600
- A Phase 1 Study of RP-1664 in People With Advanced Solid Tumors With Certain Genetic Changes
- A Phase I Study of RP-3500 Alone or with Talazoparib in People with Advanced Solid Tumors with Certain Genetic Mutations
- A Phase I/II Study of Zotatifin in People with Advanced Breast Cancer and Non-Small Cell Lung Cancer
Read more
- Clinical Trials Co-Investigated by Dr. Rosen
- A Phase 1/2 Study of BBI-355 in People With Advanced Solid Tumors
- A Phase I/II Study of PC14586 in People with Solid Tumors Containing a p53 Y220C Mutation
- A Phase I/II Study of REGN5093-M114 in People with Advanced Non-Small Cell Lung Cancer
- A Phase II Study of Lower Dose Radiation Therapy in People with Metastatic Tumors Containing a Genetic Change
- A Phase II Study of Radiation Therapy with Pembrolizumab Immunotherapy and Olaparib in Women with Triple-Negative Breast Cancer
- A Study of RP-3500 in Combination with Standard Radiation Therapy to Treat Symptoms in People with Metastatic Solid Tumors
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ezra Rosen discloses the following relationships and financial interests:
-
eFFECTOR Therapeutics
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].